Hutch News

Herpes cure with gene editing makes progress in laboratory studies

Herpes cure with gene editing makes progress in laboratory studies

Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications
News ReleasesMay 13, 2024
Discovering potential emerging SARS-CoV-2 variants

Discovering potential emerging SARS-CoV-2 variants

From the Zhao, Gilbert, Geraghty and Jerome labs, a collaboration between Public Health Sciences, Vaccine and Infectious Disease, and the Clinical Research Divisions
Science SpotlightApril 18, 2022
SARS-CoV-2 mutations associated with COVID-19 related hospitalizations

SARS-CoV-2 mutations associated with COVID-19 related hospitalizations

From the Quantitative Genetic Epidemiology Group, Jerome Lab, and Geraghty Lab. A collaboration between the Clinical Research, Public Health Sciences, and Vaccine and Infectious Disease Divisions.
Science SpotlightFebruary 21, 2022
Suppressing immunity to fight HIV infection

Suppressing immunity to fight HIV infection

From the Jerome lab, Vaccine and Infectious Disease Division
Science SpotlightNovember 16, 2020
New gene therapy approach eliminates at least 90% latent herpes simplex virus 1

New gene therapy approach eliminates at least 90% latent herpes simplex virus 1

In Nature Communications, Fred Hutch scientists demonstrate in a mouse model how gene therapy could cure an infection that afflicts billions of people
News ReleasesAugust 18, 2020